Point of care diagnostics for Cryptosporidium: new and emerging technologies
- PMID: 36504030
- DOI: 10.1097/MOG.0000000000000895
Point of care diagnostics for Cryptosporidium: new and emerging technologies
Abstract
Purpose of review: Although Cryptosporidium detection and typing techniques have improved dramatically in recent years, relatively little research has been conducted on point of care (POC) detection and typing tools. Therefore, the main purpose of the present review is to summarize and evaluate recent and emerging POC diagnostic methods for Cryptosporidium spp.
Recent findings: Microscopy techniques such as light-emitting diode fluorescence microscopy with auramine-phenol staining (LED-AP), still have utility for (POC) diagnostics but require fluorescent microscopes and along with immunological-based techniques, suffer from lack of specificity and sensitivity. Molecular detection and typing tools offer higher sensitivity, specificity and speciation, but are currently too expensive for routine POC diagnostics. Isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) or recombinase polymerase amplification (RPA) including a commercially available LAMP kit have been developed for Cryptosporidium but are prone to false positives. Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas diagnostic technologies (CRISPRDx) have recently been combined with isothermal amplification to increase its specificity and sensitivity for detection and typing. Other emerging technologies including amplification-free CRISPR detection methods are currently being developed for Cryptosporidium using a smartphone to read the results.
Summary: Many challenges are still exist in the development of POC diagnostics for Cryptosporidium. The ideal POC tool would be able to concentrate the pathogen prior to detection and typing, which is complicated and research in this area is still very limited. In the short-term, CRISPR-powered isothermal amplification lateral flow tools offer the best opportunity for POC Cryptosporidium species and subtype detection, with a fully integrated autonomous biosensor for the long-term goal.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
CRISPR-Cas-Integrated LAMP.Biosensors (Basel). 2022 Nov 17;12(11):1035. doi: 10.3390/bios12111035. Biosensors (Basel). 2022. PMID: 36421156 Free PMC article. Review.
-
Current and upcoming point-of-care diagnostics for schistosomiasis.Trends Parasitol. 2024 Jan;40(1):60-74. doi: 10.1016/j.pt.2023.10.005. Epub 2023 Nov 23. Trends Parasitol. 2024. PMID: 38000956 Review.
-
Performance and operational feasibility of two diagnostic tests for cryptosporidiosis in children (CRYPTO-POC): a clinical, prospective, diagnostic accuracy study.Lancet Infect Dis. 2021 May;21(5):722-730. doi: 10.1016/S1473-3099(20)30556-9. Epub 2020 Dec 3. Lancet Infect Dis. 2021. PMID: 33278916 Free PMC article.
-
Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.Talanta. 2022 Jun 1;243:123388. doi: 10.1016/j.talanta.2022.123388. Epub 2022 Mar 12. Talanta. 2022. PMID: 35303554 Review.
-
CRISPR/Cas12a-based on-site diagnostics of Cryptosporidium parvum IId-subtype-family from human and cattle fecal samples.Parasit Vectors. 2021 Apr 20;14(1):208. doi: 10.1186/s13071-021-04709-2. Parasit Vectors. 2021. PMID: 33879230 Free PMC article.
Cited by
-
Development and evaluation of rapid and accurate one-tube RPA-CRISPR-Cas12b-based detection of mcr-1 and tet(X4).Appl Microbiol Biotechnol. 2024 May 27;108(1):345. doi: 10.1007/s00253-024-13191-6. Appl Microbiol Biotechnol. 2024. PMID: 38801527 Free PMC article.
-
Medical prospects of cryptosporidiosis in vivo control using biofabricated nanoparticles loaded with Cinnamomum camphora extracts by Ulva fasciata.Vet World. 2024 Jan;17(1):108-124. doi: 10.14202/vetworld.2024.108-124. Epub 2024 Jan 18. Vet World. 2024. PMID: 38406364 Free PMC article.
References
-
- Yang X, Guo Y, Xiao L, Feng Y. Molecular epidemiology of human cryptosporidiosis in low- and middle-income countries. Clin Microbiol Rev 2021; 34:e00087-19.
-
- Pane S, Putignani L. Cryptosporidium: still open scenarios. Pathogens 2022; 11:515.
-
- Levine MM, Nasrin D, Acácio S, et al. Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study. Lancet Glob Health 20208; (2):e204–e214.
-
- Mihala G, Ware RS, Lambert SB, et al. Potentially pathogenic organisms in stools and their association with acute diarrheal illness in children aged <2 years. J Pediatric Infect Dis Soc 2022; 11:199–206.
-
- Johansen ØH, Abdissa A, Zangenberg M, et al. A comparison of risk factors for cryptosporidiosis and noncryptosporidiosis diarrhoea: a case–case–control study in Ethiopian children. PLoS Negl Trop Dis 2022; 16:e0010508.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous